Optimizing Treatment and Patient Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer - a podcast by ReachMD

CME credits: 0.25

Valid until: 17-05-2022

Claim your CME credit at https://reachmd.com/programs/cme/optimizing-treatment-and-patient-selection-braf-v600e-mutated-metastatic-colorectal-cancer/12437/

BRAF mCRC is a very aggressive subset of colon cancer and, until recently, treatment options have been very limited. With a new standard of care on the rise, a critical challenge remains: How will emerging regimens be utilized in daily clinical practice?

Join us as 2 experts, Dr. Scott Kopetz and Dr. Julien Taieb, examine strategies to enhance the personalized management of patients with BRAF V600E-mutated mCRC.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD